Adebrelimab Injection Clinical Trials
7 recruitingDrug
Phase 25Phase 13Not Applicable1Phase 31
Showing 1–7 of 7 trials
Recruiting
Phase 2
A Phase II Study of SHR-8068 Injection in Combination With Anti-tumor Therapies in Colorectal Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.200 enrolled1 locationNCT07071714
Recruiting
Phase 3
A Phase III Study of SHR-8068 in Combination With Adebrelimab and Platinum-Containing Chemotherapy Versus Durvalumab in Combination With Platinum-Containing Chemotherapy as First-line Treatment for Advanced Biliary Tract Cancer (BTC)
Advanced Biliary Tract Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.604 enrolled1 locationNCT07229625
Recruiting
Phase 2
A Trial of Adebrelimab Plus (SHR-A1811/SHR-A1904 With Chemotherapy) or SHR-8068 as Treatment for Gastric/GEJ Cancer
Gastric CancerGastroesophageal-junction Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.200 enrolled2 locationsNCT07110571
Recruiting
Phase 1Phase 2
A Trial of SHR-A2102 With Adebrelimab With or Without Other Antitumor Therapy in Advanced or Metastatic Non-small Cell Lung Cancer
Advanced or Metastatic Non-small Cell Lung Cancer
Shanghai Hengrui Pharmaceutical Co., Ltd.248 enrolled1 locationNCT06512051
Recruiting
Phase 1Phase 2
A Study of SHR-1826 for Injection in Combination With Other Antitumor Therapies in Subjects With Solid Tumors
Advanced Solid Tumors
Suzhou Suncadia Biopharmaceuticals Co., Ltd.876 enrolled1 locationNCT06703177
Recruiting
Phase 1Phase 2
A Clinical Study of SHR-A1811 Combined With Chemotherapy for Platinum Sensitive Recurrent Ovarian Cancer
Ovarian Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.150 enrolled1 locationNCT06840002
Recruiting
Not Applicable
Adebrelimab Plus Apatinib for Maintenance Therapy of Extensive Stage Small Cell Lung Cancer
Small Cell Lung Cancer
Yunpeng Liu38 enrolled2 locationsNCT06480864